XML 42 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Significant Segment Expenses The following table sets forth significant segment expenses.
Three Months Ended
March 31,
20262025
Research and development:
Employee and contracted employee expense$2,338 $1,100 
Other research and development4,874 2,093 
Total research and development7,212 3,193 
Selling and marketing
Employee and contracted employee expense$7,300 $2,064 
Other selling and marketing5,232 2,410 
Total selling and marketing expense12,532 4,474 
General and administrative
Employee and contracted employee expense$10,528 $6,843 
Other general and administrative11,192 2,850 
Total general and administrative expense21,720 9,693 
Total operating expenses$41,464 $17,360 
Schedule of CODM also Reviews DefenCath Sales Separately From Sales
The CODM also reviews DefenCath sales separately from sales from the Melinta Portfolio; the following table sets forth the breakdown of sales:
Three Months Ended
March 31,
20262025
Product Sales:
DefenCath$97,511 $39,082 
Melinta Portfolio24,405 - 
Total product sales121,916 39,082 
Contract Revenue5,511 - 
Total Revenues$127,427 $39,082